Moscow/Hyderabad, India, October 17, 2020 – Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announce that they have received approval from the Drug Control General of India (DCGI) to conduct an adaptive phase 2/3 human clinical trial for Sputnik V...
New process functionality native to controllers, cyber-secured architectures, and improved system availability and workflows unlocks value and...
Abdullah Salem Obaid Mohammad Al-Kaabi is a professional horse rider. With his marvelous horse riding skills, he...
Moscow, October 12, 2020 – The UAE Ministry of Health and Prevention has approved Phase III clinical...
As the Beijing Platform for Action turns 25, the UN General Assembly hosts a high-level meeting to...
Moscow, October 2, 2020 – The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, announces the...
Do you want to make a splash with your next swimsuit? If so, then it’s important to...
Businesses incredibly rely on market research to efficiently run their marketing strategies and gain an edge over...
Islamabad – September 30, 2020: United Kingdom through Karandaaz’s Risk Participation Facility with Meezan Bank, Pakistan’s first...
Facebook
Twitter
Instagram
LinkedIn
RSS